REMINDER Investor Day 8 November 2018, 12.30pm for 1.30pm

Hikma Pharmaceuticals PLC will host an Investor Day on 8 November at Bank of America Merrill Lynch Financial Centre in the King Edward Hall (2 King Edward Street, London EC1A 1HQ). Lunch will be served from 12:30pm. The presentation will commence at 1.30pm.

Press Release Corporate 1 November 2018

text

The event will be hosted by Siggi Olafsson, Chief Executive Officer, supported by Hikma’s management team. Siggi will be provide an update on his strategic priorities for the business and his management team will provide further insight into Hikma’s three business segments.

The agenda for the day is as follows:

1:30 – 1:40pm

Welcome

Said Darwazah

1:40 – 2:10pm

Delivering sustainable growth

Siggi Olafsson

2:10 – 2:30pm

Injectables

Riad Mechlaoui

Dan Motto

2:30 – 2:50pm

Generics

Brian Hoffmann

Kristy Ronco

BREAK

3:05 – 3:25pm

Branded

Mazen Darwazah

Masoud Abdelmajid

3:25 – 3:40pm

Financial overview

Khalid Nabilsi

3:40 – 3:55pm

Outlook

Siggi Olafsson

3:55 – 4:45pm

Q&A

All speakers

If you are interested in attending please contact Carissa Gilbert on 020 3727 1861 or via email to Carissa.gilbert@fticonsulting.com to register.

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.